International Clinical Trial: Association between CD22 gene SNPs and the risk of Alzheimer's disease as well as ß-amyloid deposition in the brain

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132096) titled 'Association between CD22 gene SNPs and the risk of Alzheimer's disease as well as ß-amyloid deposition in the brain' on Sept. 9.

Study Type: Observational study

Study Design: Case-Control study

Primary Sponsor: Army Medical Center of PLA

Condition: Alzheimer's Disease

Intervention: Control group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-15

Target Sample Size: Control group:400;Case group:200;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=339957

Published by HT Digital Content Services with permiss...